MJ

Mamtaben Janakbhai Dhameliya

Active Director Director DIN 10702963
DIN 10702963 First appointment Jul 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mamtaben Janakbhai Dhameliya

Data last updated:

Mamtaben Janakbhai Dhameliya is a Director at Soulter Remedies Limited (since 2024). The company operates in Paper.

DIN 10702963
Primary Designation Director
Industry Paper
First Appointment 11 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Soulter Remedies Limited U21001GJ2024PLC153350
Director11 Jul 20242024Active

Board colleagues of Mamtaben Janakbhai Dhameliya

Directorship timeline

Open interactive timeline →
Soulter Remedies Limited
Premium access

Shareholding and investment profile for Mamtaben Janakbhai Dhameliya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mamtaben Janakbhai Dhameliya

Mamtaben Janakbhai Dhameliya currently holds 1 directorship: Soulter Remedies Limited (Director, since 11 Jul 2024).

Mamtaben Janakbhai Dhameliya was first appointed on 11 Jul 2024 as Director at Soulter Remedies Limited.

The current boards of Mamtaben Janakbhai Dhameliya's companies include Aditya Niteshbhai Savaliya (Soulter Remedies Limited), Vijaybhai Vitthalbhai Bhoot (Soulter Remedies Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available